Table: Sawai Pharmaceutical -6-MTH group results
Nov 10 (Reuters)-
Sawai Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 65.42 58.96 134.50
(+11.0 pct) (+17.4 pct) (+8.9 pct)
Operating 11.36 11.61 23.50
(-2.1 pct) (+13.5 pct) (+1.4 pct)
Recurring 11.33 11.44 23.30
(-1.0 pct) (+12.4 pct) (+1.2 pct)
Net 8.57 8.50 17.50
(+0.8 pct) (+21.4 pct) (+2.0 pct)
EPS 232.33 yen 230.76 yen 474.67 yen
EPS Diluted 232.20 yen 230.57 yen
Ann Div 120.00 yen 130.00 yen
-Q2 div 65.00 yen 55.00 yen
-Q4 div 65.00 yen 65.00 yen
NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on SAWAI group
See all newsTable: Sawai Group Holdings -Q1 group results (IFRS)
Table: Sawai Group Holdings -2025/26 group results (IFRS)
Brief: Silchester International Cuts Stake In Sawai Group Holdings To 5.82% From 6.83%, Regulatory Filing Shows
Table: Sawai Group Holdings -9-MTH group results (IFRS)
Table: Sawai Group Holdings 6-MTH group results (IFRS)